Public annual accounts

DR. VERBRUGGEN financials

Name: DR. VERBRUGGEN financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR. VERBRUGGEN, with comparable measures and links to available source documents.

Company overview

Registry number

0534708243

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for DR. VERBRUGGEN

2025 versus 2024

Operating line: €699,459
EBITDA: €669,187
Total assets: €3,857,008
Equity: €3,840,637

EBITDA margin +95.7% · Equity ratio +99.6%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€699,459	€669,187	€3,857,008	€3,840,637	-
202430 Jun 2024	€467,422	€440,289	€3,405,900	€3,375,741	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report